IBD and Crohn's Disease Program Report 2014-2015
Since 2009, the Trust has provided more than $185 million in grants to find a cure for inflammatory bowel diseases (IBD) and, while awaiting that outcome, to find better therapeutic and prevention strategies. More than 100 Helmsley-funded investigators are working in nine countries to understand how human genetics, the gut microbiome and the immune system can cause and exacerbate IBD and bring those insights into the development of new treatments.
This past year was an exciting one for the Trust’s IBD and Crohn's Disease Program. The portfolio grew significantly, with much of its new grantmaking – $46.3 million – focused on launching or expanding dynamic research networks. These powerful partnerships bring together leading researchers and resources to pursue complex, critically important questions that can't be addressed alone. They represent a central strategy that the Trust believes will yield the new knowledge we need to overcome IBD.
This "year in review" highlights some of the program’s largest grants and the exciting, groundbreaking discoveries they continue to generate.